Apyx Medical Corp - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
APYX Nasdaq 3841 https://apyxmedical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apyx Medical Corp

Here's What Apyx Medical Corporation's (NASDAQ:APYX) Shareholder Ownership Structure Looks Like - Jun 15th, 2022 5:09 pm
Why Apyx Medical Shares Are Trading Higher Today? - May 26th, 2022 4:20 pm
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures - May 26th, 2022 12:30 pm
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June - May 25th, 2022 8:05 pm
Those who invested in Apyx Medical (NASDAQ:APYX) five years ago are up 70% - May 16th, 2022 4:53 pm
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates - May 12th, 2022 12:15 pm
Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook - May 12th, 2022 11:00 am
Quidel (QDEL) Q1 Earnings and Revenues Top Estimates - May 4th, 2022 9:55 pm
LeMaitre Vascular (LMAT) Q1 Earnings Miss Estimates - Apr 28th, 2022 9:55 pm
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022 - Apr 4th, 2022 8:05 pm
Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin - Apr 4th, 2022 11:00 am
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook - Mar 17th, 2022 11:00 am
Apyx Medical Corporation Notified of Pending FDA Medical Device Safety Communication Related to its Advanced Energy Products - Mar 14th, 2022 11:00 am
Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member - Mar 1st, 2022 9:05 pm
Molina (MOH) to Join S&P 500 Driven by Medicare Performance - Feb 28th, 2022 5:01 pm
Apyx Medical Submits Additional FDA 510(k) For Expanded Use Of Renuvion In Dermatological Procedures - Feb 17th, 2022 5:26 pm
Apyx Medical Corporation Announces Peer-Reviewed Publication Featuring Results from the U.S. IDE Clinical Study Evaluating the Renuvion® Dermal Handpiece Using Apyx’s Helium Plasma Technology for Dermal Resurfacing Procedures - Feb 17th, 2022 12:30 pm
A Look At The Intrinsic Value Of Apyx Medical Corporation (NASDAQ:APYX) - Feb 15th, 2022 10:08 am
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022 - Jan 27th, 2022 12:30 pm
Medtronic (MDT) Undertakes Investment to Advance STEM Education - Jan 24th, 2022 2:52 pm